Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07240)

• Formulation Name: Enalapril 2.5 mg tablet
• Company: Ranbaxy Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Enalapril	(DMNFUZR)	Congestive heart failure	BD10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Maleic acid	(E00418)	444266	Acidulant; Buffering agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Zinc stearate	(E00209)	11178	lubricant